1. Screening for Fabry disease in patients with ischaemic stroke at young age: the Italian Project on Stroke in Young Adults. (March 2017) Authors: Poli, L.; Zedde, M.; Zini, A.; Del Sette, M.; Lodigiani, C.; Spalloni, A.; Di Lisi, F.; Toriello, A.; Piras, V.; Stilo, C.; Tomelleri, G.; Tancredi, L.; Paciaroni, M.; Silvestrelli, G.; Adami, A.; Costa, P.; Morotti, A.; De Giuli, V.; Caria, F.; Gamba, M. Other Names: Del Zotto Elisabetta investigator.; Giossi Alessia investigator.; Sessa Maria investigator.; Gilberti Nicola investigator.; Magoni Mauro investigator.; Ferrazzi Paola investigator.; Librè Luca investigator.; Rota Lidia Luciana investigator.; Patella Rosalba investigator.; Di Liso Filomena investi... Journal: European journal of neurology Issue: Volume 24:Number 3(2017:Mar.) Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long‐term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients. (18th November 2020) Authors: Nettis, E.; Fabbrocini, G.; Ortoncelli, M.; Pellacani, G.; Argenziano, G.; Di Leo, E.; Patruno, C.; Stingeni, L.; Foti, C.; Rongioletti, F.; Macchia, L.; Tavecchio, S.; Napolitano, M.; Ribero, S.; Bonzano, L.; Calabrese, G.; Di Bona, D.; Nisticò, S.P.; Hansel, K.; Romita, P. Journal: British journal of dermatology Issue: Volume 184:Number 3(2021) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients. (1st March 2021) Authors: Nettis, E.; Fabbrocini, G.; Ortoncelli, M.; Pellacani, G.; Argenziano, G.; Di Leo, E.; Patruno, C.; Stingeni, L.; Foti, C.; Rongioletti, F.; Macchia, L.; Tavecchio, S.; Napolitano, M.; Ribero, S.; Bonzano, L.; Calabrese, G.; Di Bona, D.; Nisticò, S.P.; Hansel, K.; Romita, P. Journal: British journal of dermatology Issue: Volume 184:Number 3(2021) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32‐week real‐world experience during the COVID‐19 pandemic. (1st January 2022) Authors: Hansel, K.; Patruno, C.; Antonelli, E.; Dal Bello, G.; Napolitano, M.; Fabbrocini, G.; Grieco, T.; Pellacani, G.; Fargnoli, M. C.; Esposito, M.; Piras, V.; Zucca, M.; Girolomoni, G.; Stingeni, L. Journal: Clinical and experimental dermatology Issue: Volume 47:Number 1(2022) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Oral Signs and HLA-DQB1*02 Haplotypes in the Celiac Paediatric Patient: A Preliminary Study. (3rd October 2013) Authors: Erriu, M.; Abbate, G. M.; Pili, F. M. G.; Novara, F.; Orrù, G.; Montaldo, C.; Piras, V.; Levrini, L. Other Names: Nenna Raffaella Academic Editor. Journal: Autoimmune diseases Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗